This is the second in a series of three pieces on corporate readiness to fight avian flu. The FT finds the drugs industry does not have insider knowledge

For companies focused on the treatment of other peoples’ illnesses, the world’s big pharmaceutical groups have been reflecting for several months on how best to protect their own staff and businesses in the event of a flu pandemic.